AdAlta Limited is a drug discovery and development company focused on using its powerful technology platform to generate a promising new class of protein therapeutics, known as i-bodies, for treating a wide range of human diseases. i-bodies are a human analogue of the antigen binding domain of the shark antibody; they combine the high target specificity and affinity advantages of antibodies with the beneficial features of small molecule drugs.
Biosensis specializes in antibodies and reagents for Neuroscience, with particular emphasis on neurotrophins and neurotrophin receptors for which Biosensis’ founders and scientists have been the worldwide leader and OEM supplier for nearly 30 years. In addition to neurotrophins, our neuroscience portfolio includes products for research in neurodegenerative diseases, neurodevelopment, and neuro-metabolism. Areas of focus include Alzheimer’s, Parkinson’s and ALS diseases, as well as autophagy and metabolic and stress disorders including metabolic syndrome research, obesity, and neuroimmunology and inflammation.
Founded in 2010, B-TEMIA Inc. is a privately-owned dermoskeletic technology company. Based in Quebec City, Canada, B-TEMIA develops, manufactures and commercializes cutting-edge products in the growing market of human augmentation systems.
B-TEMIA’s proprietary wearable Dermoskeleton™ technology provides the user with robotized mechanical support to restore, maintain or enhance the mobility of users, with applications in the medical, industrial and military fields.
In addition to its two wholly-owned subsidiaries, B-TEMIA Health Inc and B-TEMIA Military Inc, the Company also operates under its wholly-owned subsidiary, B-TEMIA USA, Inc.
The Company aims to become the global leader in the high growth market of human augmentation, by developing innovative high-value mobility assistive devices that enable individuals to regain their autonomy.
CIMTECH is a natural products research and development company that draws on the traditional medicines of the Cook Islands to bring new natural beauty skincare, cosmeceuticals, dermatological and pharmaceutical products to the market.
Clarity Pharmaceuticals is a personalised medicine company focused on the treatment of serious disease. The Company is a leader in innovative radiopharmaceutical technology, developing targeted therapies and assisting in the drug development pipeline of novel therapies for companies globally.
Gamma Vaccines is an Australian company targeting primarily the human and avian influenza market.Gamma Vaccines manufactures and kills influenza virus in a manner that preserves the proper structure of the virus and its various proteins. By using gamma irradiation – a procedure in wide-spread use to sterilize surgical instruments and stop spoilage of perishable fruits – a killed virus preparation can be obtained that is no longer infectious and which induces a potent immunity to different influenza virus strains and subtypes.
Impleo Medical is a private company located in St. Paul, Minnesota. The Company has developed a proprietary bulking agent therapy for Gastric Esophageal Reflux Disease (GERD). Impleo’s management team has many years of experience in medical devices and is supported by an outstanding Board of Directors as well as recognized clinical leaders in the field of gastroenterology. Impleo’s bulking agent is injected under sedation in the lower esophageal sphincter. It is designed to create a bulge and prevent or reduce the flow of gastric acid into the esophagus. Impleo has strong intellectual property which protects our invention. The bulking agent is CE-marked in Europe for the treatment of GERD. It is currently under clinical investigation in the United States.
(Acquired by Optos plc (LSE: OPTS) (“Optos”)). Opto Global is an ophthalmic innovator offering an advanced range of precision ophthalmic and optometric equipment through an extensive worldwide independent distributor network. Opto’s focus is to deliver early detection and treatment devices for glaucoma, cataract and AMD (Age-related Macular Degeneration), the most common causes of blindness.
Orthocell is a world leading regenerative medicine company, dedicated to providing innovative treatments for people suffering from tendon, cartilage and soft tissue injuries.
Prancing Pony Brewery
Prancing Pony is an award winning craft brewery in the Adelaide Hills. Established in 2012, Prancing Pony Brewery moved to its current location at Totness, in 2015 and has gone from strength to strength. The founders planned to become a sizeable brewery and be a major contributor to the craft beer industry across Australia and recently won the pinnacle of awards at the International Beer Challenge (IBC) in London, with its India Red Ale crowned Supreme Champion Beer in 2016.
GR is a specialist immunoassay technology company. Underpinning TGR’s immunoassays is CaptSure™ – a patented antibody immobilisation system that delivers improvements in assay speed, simplicity and performance. Applications include bead-based assays, ELISA and microfluidics for both life sciences and diagnostics markets.
Our flagship products, SureFire® and SureFire® Ultra™, cater for high throughput analysis of phosphoproteins using a no-wash, bead-based technology.